Parameters of Cardiac Electrical Instability in Chronic Haemodialysis Patients
American Journal of Internal Medicine
Volume 3, Issue 3, May 2015, Pages: 78-85
Received: Mar. 9, 2015; Accepted: Mar. 17, 2015; Published: Mar. 23, 2015
Views 3130      Downloads 216
Authors
Ahmed Abdel-Galeel, Cardiology Department, Assiut University Hospitals, Assiut, Egypt
Lobna Abdel-Wahid, Internal Medicine Department, Assiut University Hospitals, Assiut, Egypt
Samir Kamal Abdulhamid, Internal Medicine Department, Assiut University Hospitals, Assiut, Egypt
Ahmed Obiedallah, Internal Medicine Department, Assiut University Hospitals, Assiut, Egypt
Mohammed Aboel-Kassem Farghal Abdelmegid, Cardiology Department, Assiut University Hospitals, Assiut, Egypt
Hanan Sharaf El-Deen Mohammed, Internal Medicine Department, Assiut University Hospitals, Assiut, Egypt
Article Tools
Follow on us
Abstract
Background: A large proportion of cardiovascular mortality in dialysis patients is caused by sudden death that is related to the dialysis procedure. Parameters of heart rate variability, P wave duration and dispersion and rate corrected QT and QT dispersion are readily used to assess cardiac electrical stability. However, there are relatively few data discussing the factors associated with arrhythmia in dialysis patients. Methods: The study included 30 patients on regular haemodialysis. All patients had full history taking (age, sex, duration of haemodialysis in months and smoking history), clinical examination, laboratory investigations (serum Mg, K, Na and complete blood picture), echocardiography and 24-hours Holter recording. Results: The study included 30 patient on regular haemodialysis (mean duration 30.9±13.2 months), 53.3% males with mean age 43.9±10.1 years. All ECG and Holter derived parameters showed statistically significant changes during haemodialysis. There were increase in P wave duration and dispersion, rate corrected QT interval and QT dispersion and decrease in heart rate variability, that are arrhythmogenic. Moreover, the incidence of both supraventricular and ventricular ectopics increased during dialysis. Smoking and long term dialysis were associated with more arrhythmia risk. Conclusions: Patients on regular haemodialysis are susceptible to cardiac arrhythmias. The process of haemodialysis itself is arrhythmogenic. Smoking and long term haemodialysis are associated with higher incidence of cardiac electrical instability.
Keywords
Haemodialysis, Arrhythmia, Smoking
To cite this article
Ahmed Abdel-Galeel, Lobna Abdel-Wahid, Samir Kamal Abdulhamid, Ahmed Obiedallah, Mohammed Aboel-Kassem Farghal Abdelmegid, Hanan Sharaf El-Deen Mohammed, Parameters of Cardiac Electrical Instability in Chronic Haemodialysis Patients, American Journal of Internal Medicine. Vol. 3, No. 3, 2015, pp. 78-85. doi: 10.11648/j.ajim.20150303.11
References
[1]
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47:884–890.
[2]
Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69:2268–2273.
[3]
Selby NM. and Mc Intyre CW: The Acute Cardiac Effects of Dialysis. Seminars in Dialysis. 2007; 20: 220–228.
[4]
Roberts MA, Polkinghorne KR, McDonald SP, Ierino FL. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011; 58: 64–72.
[5]
Reyes Del Paso GA, Langewitz W, Mulder LJM, Van Roon A, Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone :a review with emphasis on a reanalysis of previous studies. Psychophysiology 2013; 50: 477–487.
[6]
Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164–171.
[7]
Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 1999; 14: 1480–1488
[8]
Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N, Ojika K, Yagi K, Matsumoto H, Sohmiya S, Kimura G. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003; 18: 318-325.
[9]
Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart. 2014; 100: 685-690.
[10]
Tezcan UK, Amasyali B, Can I, Aytemir K, Köse S, Yavuz I, Kursaklioglu H, Işik E, Demirtaş E, Oto A. Increased P wave dispersion and maximum P wave duration after hemodialysis. Ann Noninvasive Electrocardiol. 2004; 9: 34-38.
[11]
Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ. Torsade de pointes: the clinical considerations. Int J Cardiol. 2004; 96:1-6.
[12]
Pye M, Quinn AC, Cobbe SM: QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1994; 71: 511–514.
[13]
Maule S, Veglio M, Mecca F, Calvo C, Martina G, Marangella M, Quadri R, Cavallo Perin P. Autonomic neuropathy and QT interval in hemodialysed patients. Clin Auton Res 2004; 14: 233–239.
[14]
Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysis induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Renal Failure 2008; 30: 701–709.
[15]
Bonato FO, Lemos MM, Cassiolato JL, Canziani ME. Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients. PLoS One. 2013; 8 (6) : e66036.
[16]
Kimura G, Tomita J, Nakamura S, Uzu T, Inenaga T. Interaction between hypertension and other cardiovascular risk factors in survival of hemodialyzed patients. Am J Hypertens 1996; 9: 1006–1012
[17]
Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, Stella A, Vincenti A. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009; 24: 2529 –2536.
[18]
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17: 2034-2047.
[19]
Foley RN, Parfrey PS, Harnett JD, Kent GM, Hu L, O'Dea R, Murray DC, Barre PE. Hypocalcemia, morbidity and mortality in end-stage renal disease. Am J Nephrol. 1996; 16: 386-393.
[20]
Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003; 64: 254-262.
[21]
Hecking E, Bragg-Gresham JL, Rayner HC, Pisoni RL, Andreucci VE, Combe C, Greenwood R, McCullough K, Feldman HI, Young EW, Held PJ, Port FK. Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004; 19: 100-107.
[22]
Severi S, Pogliani D, Fantini G, et al. Alterations of atrial electrophysiology induced by electrolyte variations: combined computational and P-wave analysis. Europace 2010; 12: 842–849.
[23]
Severi S, Grandi E, Pes C, Fabbrini P, Vigano` MR, Galbiati E, Bonforte G, Vincenti A, Stella A, Genovesi S. Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis. Nephrol Dial Transplant 2008; 23: 1378–1386.
[24]
Yetkin E, Ileri M, Tandogan I, Boran M, Yanik A, Hisar I, Kutlu M, Cehreli S, Korkmaz S, Goksel S. Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients. Angiology 2000; 51:499–504.
[25]
Covic A, Diaconita M, Gusbeth-Tatomir P, Covic M, Botezan A, Ungureanu G, Goldsmith DJ. Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 2002; 17: 2170–2177.
[26]
Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10: 88–101.
[27]
Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V. Uraemic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999; 56: 232–237
[28]
Tong YQ, Hou HM. Alteration of heart rate variability parameters in nondiabetic haemodialysis patients. Am J Nephrol 2007; 27: 63–69
[29]
Bleyer A, Hartman J, Brannon PC, Satko SG. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 88: 2268–2273.
[30]
Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysis induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Renal Failure 2008; 30: 701–709.
[31]
Khan IH, Catto GR, Edward N, MacLeod AM. Death during the first 90 days of dialysis: a case control study. Am J Kidney Dis 1995; 25: 276-280.
[32]
Owen WF, Madore F, Brenner BM. An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis 1996; 28: 931-936.
[33]
Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
[34]
Saygi S, Asci G, Dheir H, Duman S, Kayikcioglu M, Yilmaz M, Ozkahya M, Ok E. Ventricular arrhythmia in dialysis patients: a link with higher hemoglobin levels? Hemodial Int. 2011; 15: 250-255.
[35]
Shimizu Y, Koro T, Koyama A. Patients with complex ventricular arrhythmias during hemodialysis suffer from unstable blood pressure. Internet J Nephrol 2004 Volume 2 Number 1.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186